Epigenetics in Ascending Thoracic Aortic Aneurysm and Dissection.

Area of Science:

• Cardiovascular Research
• Genetics and Epigenetics
• Translational Medicine

Background:

• Thoracic aortic aneurysm (TAA) and ascending aortic dissection (AAD) are life-threatening conditions with shared genetic links.
• Current treatments for TAA and AAD primarily involve surgical interventions with significant risks.
• A deeper understanding of the molecular mechanisms underlying TAA and AAD pathogenesis is essential for developing novel therapies.

Purpose of the Study:

• To review the role of epigenetic regulation in the pathogenesis of TAA and AAD.
• To explore how epigenetic modifications influence gene expression in aortic diseases.
• To highlight the potential of epigenetics for developing new diagnostic and therapeutic approaches.

Main Methods:

• Review of current literature on epigenetic mechanisms in TAA and AAD.
• Focus on histone methylation, histone acetylation, DNA methylation, and noncoding RNAs.
• Analysis of translational data linking epigenetic alterations to disease progression.

Main Results:

• Epigenetic alterations, including DNA methylation and histone modifications, are implicated in the development and progression of TAA and AAD.
• Noncoding RNAs also play a significant role in regulating gene expression relevant to aortic wall integrity.
• These epigenetic changes affect key cellular processes such as smooth muscle cell function and extracellular matrix integrity.

Conclusions:

• Epigenetic dysregulation is a key factor in the pathogenesis of TAA and AAD.
• Targeting epigenetic mechanisms offers promising avenues for novel theranostic strategies.
• Further research into epigenetics could revolutionize the diagnosis and treatment of aortic diseases.